MAGIC-01: A study of a new vaccine against Marburg virus in adults aged 18 – 55 years

By OVG

THIS STUDY IS CLOSED FOR RECRUITMENT

You are invited to take part in a study to investigate a new vaccine against Marburg virus. The study is being led by the Oxford Vaccine Group, which is part of the University of Oxford. The study will take place at the Oxford Vaccine Group, Centre for Clinical Vaccinology & Tropical Medicine (CCVTM).

Oct

24

2023

NIV001

By OVG

Study Title: NIV001

NIV001: A phase I safety and immunogenicity trial of a Nipah virus vaccine, ChAdOx1 NipahB, in healthy volunteers aged 18-55 years in the UK

Sep

14

2023

The 6-in-1 Part 2 Vaccine Study

By OVG

The 6-in-1 Part 2 Vaccine Study

Recruiting now for The 6-in-1 Part 2 Vaccine Study. Oxford Vaccine Group, University of Oxford would like to invite your child to take part in a study to help guide future changes to the UK immunisation schedule. We want to enroll healthy children, who have not yet received their 12-month routine vaccinations and were born prematurely.

Aug

18

2023

BIO-001

By OVG

We are looking for healthy volunteers to take part in a study to find a vaccine against Malaria.

Jul

09

2018

POInT

By OVG

The Oxford Vaccine Group is recruiting infants aged 4 – 7 months to a type 1 diabetes prevention trial. POInT (Primary Oral Insulin Trial) is recruiting infants who were screened for diabetes at birth through the INGR1D Study and have been found to be at high risk for developing diabetes.

Jun

21

2017

Vaccine Attitudes: A Series of Focus Groups

By OVG

Are you a parent or guardian of a child aged 0-5 years?
You may be interested in taking part in a study about vaccine attitudes.
This study is run by Oxford Vaccine Group, part of the University of Oxford.

What is the study about?

We will be holding focus groups (discussions) with small groups of parents of children aged 0-5 years.